Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
Anti-TNF-α agents are currently utilised for the treatment of a vast array of autoimmune conditions including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis and psoriasis. It is however noted that such therapeutic strategies have been linked to the specific induction of cut...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2009-11-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/257907 |
id |
doaj-9139b6b916ee4fa991dba4a377ec1265 |
---|---|
record_format |
Article |
spelling |
doaj-9139b6b916ee4fa991dba4a377ec12652020-11-25T01:48:48ZengKarger PublishersCase Reports in Gastroenterology1662-06312009-11-013340440710.1159/000257907257907Anti-TNF-Alpha-Induced Psoriasis – An Unusual ParadoxNeel SharmaJames LindsayAnti-TNF-α agents are currently utilised for the treatment of a vast array of autoimmune conditions including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis and psoriasis. It is however noted that such therapeutic strategies have been linked to the specific induction of cutaneous-based reactions such as dermatitis, erythema multiforme and psoriasis. Here we present the case of a young female patient with Crohn’s disease who developed psoriasis following treatment with the anti-TNF-α drug adalimumab and highlight the possible pathogenetic mechanisms involved in such an occurrence.http://www.karger.com/Article/FullText/257907Anti-TNF-alphaPsoriasisCrohn’s disease |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Neel Sharma James Lindsay |
spellingShingle |
Neel Sharma James Lindsay Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox Case Reports in Gastroenterology Anti-TNF-alpha Psoriasis Crohn’s disease |
author_facet |
Neel Sharma James Lindsay |
author_sort |
Neel Sharma |
title |
Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox |
title_short |
Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox |
title_full |
Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox |
title_fullStr |
Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox |
title_full_unstemmed |
Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox |
title_sort |
anti-tnf-alpha-induced psoriasis – an unusual paradox |
publisher |
Karger Publishers |
series |
Case Reports in Gastroenterology |
issn |
1662-0631 |
publishDate |
2009-11-01 |
description |
Anti-TNF-α agents are currently utilised for the treatment of a vast array of autoimmune conditions including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis and psoriasis. It is however noted that such therapeutic strategies have been linked to the specific induction of cutaneous-based reactions such as dermatitis, erythema multiforme and psoriasis. Here we present the case of a young female patient with Crohn’s disease who developed psoriasis following treatment with the anti-TNF-α drug adalimumab and highlight the possible pathogenetic mechanisms involved in such an occurrence. |
topic |
Anti-TNF-alpha Psoriasis Crohn’s disease |
url |
http://www.karger.com/Article/FullText/257907 |
work_keys_str_mv |
AT neelsharma antitnfalphainducedpsoriasisanunusualparadox AT jameslindsay antitnfalphainducedpsoriasisanunusualparadox |
_version_ |
1725010081153548288 |